GNPX today
$2.21-$0.08 (-3.49%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourSymmetric Triangle
15 minBearish
5 minStrong Bullish
Daily trend turns up above $4.20
Key levels
Resistance$2.70
Resistance$2.38
Support$1.71
Latest news & SEC filings
NewsGenprex reports REQORSA analysis shows shift toward cellular maintenance
ProductGenprex flags TROP2 as possible marker for REQORSA response
All GNPX news →About Genprex
Genprex is a clinical-stage gene therapy company developing treatments for cancer and diabetes. Its lead oncology candidate, REQORSA, uses a non-viral delivery system to deliver tumor suppressor genes and is being tested in combination with approved drugs for non-small cell and small cell lung cancer. The company also has a preclinical diabetes program using an AAV vector to deliver Pdx1 and MafA genes into the pancreatic duct, licensed from the University of Pittsburgh. It operates in the United States.
Based on the company's 10-K filed Mar 30, 2026.
Nasdaq · Healthcare
Genprex, Inc. (GNPX)
What Is the Price Target for GNPX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is GNPX a Buy or Sell Right Now?
Thesis
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GNPX.
Start Free Trial →Is GNPX Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
12
Moat Score
NONE
4/9
Piotroski Score
-27.3
Altman Z-Score
What Is Smart Money Doing with GNPX?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
BUYING
2 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →GNPX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for GNPX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for GNPX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:31:08 | $2.28 | 2,200 | $$5K | BUY |
| 14:57:33 | $2.23 | 1,197 | $$3K | SELL |
| 22:44:34 | $2.18 | 1,100 | $$2K | SELL |
| 20:41:59 | $2.24 | 1,300 | $$3K | SELL |
| 20:41:59 | $2.24 | 2,200 | $$5K | SELL |
5 dark pool trades shown · $$18K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Genprex, Inc. (GNPX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →GNPX — frequently asked questions
What is GNPX stock price today?
Genprex, Inc. (GNPX) is at $2.21, down 3.49% (-$0.08) at the Nov 12, 2026 close.
Why is GNPX stock moving today?
Latest GNPX news — Nov 5, 2026: Genprex reports REQORSA analysis shows shift toward cellular maintenance · Nov 5, 2026: Genprex flags TROP2 as possible marker for REQORSA response
Did GNPX beat earnings?
GNPX last reported on Aug 14, 2026: EPS -$9.40.
Does GNPX pay a dividend?
Yes. GNPX's dividend yield is 8123.16%.
What are GNPX support and resistance levels?
Support: $1.71. Resistance: $2.38, $2.70, $3.41.
What are insiders doing with GNPX?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on GNPX?
Nov 5, 2026: Genprex reports REQORSA analysis shows shift toward cellular maintenance · Nov 5, 2026: Genprex flags TROP2 as possible marker for REQORSA response